The main UTOPIA study was the first RCT to assess the effect of SGLT2 inhibitors on carotid atherosclerosis, which demonstrated a significant decrease in IMT with tofogliflozin treatment. The gene discussed is SLC5A2; the disease is carotid atherosclerosis.